Genetic mechanisms of drug resistance. A review.

An overview of our present understanding of mechanisms of resistance against cytotoxic drugs is presented. Most of this understanding has come from studies on tumor cells made resistant in vitro, but there is reason to think that similar mechanisms are responsible for resistance in patients. After a brief overview of biochemical mechanisms of drug resistance, the types of mutations in tumor cells that can alter drug handling are discussed. Three examples of resistance are analysed in more detail: resistance to the folate analogue methotrexate; the multidrug resistance caused by increased levels of P-glycoprotein, which extrudes drugs from the cell; and resistance to alkylating agents.

[1]  B. Spengler,et al.  Metaphase chromosome anomaly: association with drug resistance and cell-specific products. , 1976, Science.

[2]  J. Bertino,et al.  Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells. , 1978, The Journal of biological chemistry.

[3]  V. Ling,et al.  Dominance of colchicine resistance in hybrid CHO cells , 1978, Somatic cell genetics.

[4]  H. H. Lloyd,et al.  Experimental therapeutics and kinetics: selection and overgrowth of specifically and permanently drug-resistant tumor cells. , 1978, Seminars in hematology.

[5]  Goldie Jh,et al.  A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. , 1979 .

[6]  C. Heidelberger,et al.  Role of thymidylate synthetase activity in development of methotrexate cytotoxicity. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[7]  T. Seno,et al.  Resistance to methotrexate in thymidylate synthetase-deficient mutants of cultured mouse mammary tumor FM3A cells. , 1981, Cancer research.

[8]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[9]  J. Milbrandt,et al.  DNA sequence amplification in mammalian cells. , 1984, International review of cytology.

[10]  J. Trent,et al.  Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  G. Goldenberg,et al.  Alterations of Drug Transport , 1984 .

[12]  R. Schimke,et al.  Gene amplification in a leukemic patient treated with methotrexate. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  J. Schornagel,et al.  Resistance to methotrexate due to gene amplification in a patient with acute leukemia. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  R. Schimke.  Gene amplification in cultured animal cells , 1984, Cell.

[15]  A. Jacquemin-Sablon,et al.  Expression of drug sensitivity and tumorigenicity in intraspecies hybrids between 9-hydroxyellipticine-sensitive and -resistant cells. , 1984, Cancer research.

[16]  M. Fox,et al.  Antitumor Drug Resistance , 1984, Handbook of Experimental Pharmacology.

[17]  W. Ross,et al.  Characterization of VP-16-induced DNA damage in isolated nuclei from L1210 cells. , 1984, Biochimica et biophysica acta.

[18]  V. Ling,et al.  Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  A. Harris.  DNA repair and resistance to chemotherapy. , 1985, Cancer surveys.

[20]  I. Pastan,et al.  Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. , 1986, Science.

[21]  G. Stark,et al.  Structure of DNA formed in the first step of CAD gene amplification. , 1986, The EMBO journal.

[22]  A. Harris,et al.  Isolation and characterization of a Chinese hamster ovary cell line resistant to bifunctional nitrogen mustards. , 1986, Cancer research.

[23]  Y. Pommier,et al.  Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors. , 1986, Cancer research.

[24]  D. Housman,et al.  Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins , 1986, Cell.

[25]  J. Gordon,et al.  Systemic resistance to methotrexate in transgenic mice carrying a mutant dihydrofolate reductase gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[26]  W. Ross,et al.  Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug-stimulated DNA cleavage activity. , 1986, Cancer research.

[27]  Michael M. Gottesman,et al.  Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells , 1986, Cell.

[28]  Stark Gr.  DNA amplification in drug resistant cells and in tumours. , 1986 .

[29]  J. Bertino,et al.  Clinical aspects of drug resistance. , 1986, Cancer surveys.

[30]  A. Harris,et al.  Reduced levels of drug-induced DNA cross-linking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glutathione S-transferase activity. , 1987, Cancer research.

[31]  T. Rushmore,et al.  Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Mirski,et al.  Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. , 1987, Cancer research.

[33]  T. Tsuruo,et al.  Decreased expression of the amplified mdr1 gene in revertants of multidrug-resistant human myelogenous leukemia K562 occurs without loss of amplified DNA , 1987, Molecular and cellular biology.

[34]  J. Wang.  Recent studies of DNA topoisomerases. , 1987, Biochimica et biophysica acta.

[35]  J. Isbister,et al.  DETECTION OF A MULTIDRUG RESISTANT PHENOTYPE IN ACUTE NON-LYMPHOBLASTIC LEUKAEMIA , 1987, The Lancet.

[36]  T. Tsuruo,et al.  Detection of multidrug resistance markers, P-glycoprotein and mdr1 mRNA, in human leukemia cells. , 1987, Japanese journal of cancer research : Gann.

[37]  M. Center,et al.  Adriamycin resistance in HL60 cells and accompanying modification of a surface membrane protein contained in drug-sensitive cells. , 1987, Cancer research.

[38]  M C Willingham,et al.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[39]  B. Teicher,et al.  Collateral methotrexate resistance in cultured human head and neck carcinoma cells selected for resistance to cis-diamminedichloroplatinum(II). , 1987, Cancer research.

[40]  A. M. van der Bliek,et al.  Structure of amplified DNA, analyzed by pulsed field gradient gel electrophoresis , 1987, Journal of cellular biochemistry.

[41]  S. Thorgeirsson,et al.  Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver. , 1987, Science.

[42]  J. Bertino,et al.  Design and rationale for novel antifolates. , 1987, NCI monographs : a publication of the National Cancer Institute.

[43]  I. Pastan,et al.  A monoclonal antibody-Pseudomonas toxin conjugate that specifically kills multidrug-resistant cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[44]  I. Pastan,et al.  Expression of a multidrug-resistance gene in human tumors and tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[45]  V. Ling,et al.  P-glycoprotein in human sarcoma: evidence for multidrug resistance. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  Sirotnak Fm.  Determinants of resistance to antifolates: biochemical phenotypes, their frequency of occurrence and circumvention. , 1987 .

[47]  K. Tew,et al.  Mechanisms of Drug Resistance in Neoplastic Cells , 1988 .

[48]  R. J. Franco,et al.  Inhibitors of DNA topoisomerases. , 1988, Biochemistry.

[49]  B. Gallie,et al.  A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell lines. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[50]  B. Teicher,et al.  5 – Resistance to Alkylating Agents: Basic Studies and Therapeutic Implications , 1988 .

[51]  D. Suttle,et al.  Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26. , 1988, Biochemistry.

[52]  J. Wang,et al.  Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[53]  A. M. van der Bliek,et al.  Circular DNA of 3T6R50 double minute chromosomes. , 1988, Nucleic acids research.

[54]  F. Baas,et al.  Genes amplified and overexpressed in human multidrug-resistant cell lines. , 1988, Cancer research.

[55]  I. Pastan,et al.  ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[56]  R. Ozols,et al.  Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. , 1988, Biochemical pharmacology.

[57]  D. W. Fry,et al.  Characterization of trimetrexate transport in human lymphoblastoid cells and development of impaired influx as a mechanism of resistance to lipophilic antifolates. , 1988, Cancer research.

[58]  Y. Cheng,et al.  Combined modalities of resistance in etoposide-resistant human KB cell lines. , 1988, Cancer research.

[59]  J. Trent,et al.  Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines. , 1988, Cancer research.

[60]  M. Kashani-Sabet,et al.  Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[61]  R. Kramer,et al.  Role of the glutathione redox cycle in acquired and de novo multidrug resistance. , 1988, Science.

[62]  S. Kaye,et al.  The multidrug resistance phenotype. , 1988, British Journal of Cancer.

[63]  T. Tsuruo,et al.  Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. , 1988, Cancer research.

[64]  T. Tsuruo.  MECHANISMS OF MULTIDRUG RESISTANCE AND IMPLICATIONS FOR THERAPY , 1988, Japanese journal of cancer research : Gann.

[65]  M. Gottesman.  Multidrug resistance during chemical carcinogenesis: a mechanism revealed? , 1988, Journal of the National Cancer Institute.

[66]  A. Harris,et al.  Amplification and increased expression of alpha class glutathione S-transferase-encoding genes associated with resistance to nitrogen mustards. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[67]  I. Pastan,et al.  Measurement of multidrug-resistance messenger RNA in urogenital cancers; elevated expression in renal cell carcinoma is associated with intrinsic drug resistance. , 1988, The Journal of urology.

[68]  I. Pastan,et al.  The multidrug transporter, a double-edged sword. , 1988, The Journal of biological chemistry.

[69]  D. Housman,et al.  The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[70]  V. Ling,et al.  Mechanism of multidrug resistance. , 1988, Biochimica et biophysica acta.

[71]  D. Hamer,et al.  Overexpression of metallothionein confers resistance to anticancer drugs. , 1988, Science.

[72]  I. Roninson,et al.  An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene , 1988, Cell.

[73]  A. Safa.  Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[74]  A. Tulpule,et al.  Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line. , 1988, The Journal of biological chemistry.

[75]  J. Goldie,et al.  2 – Mathematical Modeling of Drug Resistance , 1988 .

[76]  R T Schimke,et al.  Gene amplification in cultured cells. , 1988, The Journal of biological chemistry.

[77]  S. Thorgeirsson,et al.  Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics. , 1988, Journal of the National Cancer Institute.

[78]  J. Lankelma,et al.  Induction by verapamil of a rapid increase in ATP consumption in multidrug‐resistant tumor cells , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[79]  B. Teicher,et al.  Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance. , 1989, Cancer research.

[80]  J. Bourhis,et al.  Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. , 1989, Journal of the National Cancer Institute.

[81]  T Appenzeller,et al.  Thinking in circles. , 1989, Scientific American.

[82]  I. Pastan,et al.  Expression of a human multidrug resistance gene in ovarian carcinomas. , 1989, Cancer research.

[83]  J. Horváth,et al.  Non-p-glycoprotein-mediated multidrug resistance in detransformed rat cells selected for resistance to methylglyoxal bis(guanylhydrazone). , 1989, Cancer research.

[84]  B. Schweitzer,et al.  Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with decreased binding to methotrexate in a human colon carcinoma cell line, HCT-8R4, resistant to this drug. , 1989, The Journal of biological chemistry.

[85]  G. Hofmann,et al.  Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. , 1989, Biochemistry.

[86]  Richard P. Hill,et al.  The Basic Science of Oncology , 1989 .

[87]  J. Lankelma,et al.  Correlation of multidrug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells , 1989 .

[88]  P. Jeggo,et al.  Sensitivity of Chinese hamster ovary mutants defective in DNA double strand break repair to topoisomerase II inhibitors. , 1989, Cancer research.

[89]  J. Schornagel,et al.  Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance. , 1989, Cancer research.

[90]  I. Pastan,et al.  MDR1 gene expression in lung cancer. , 1989, Journal of the National Cancer Institute.

[91]  DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage. , 1989, Molecular and cellular biology.

[92]  J. Willson,et al.  Methotrexate and dipyridamole combination chemotherapy based upon inhibition of nucleoside salvage in humans. , 1989, Cancer research.

[93]  M C Willingham,et al.  Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[94]  J. Endicott,et al.  The biochemistry of P-glycoprotein-mediated multidrug resistance. , 1989, Annual review of biochemistry.

[95]  T. Tsuruo,et al.  Expression of the mdr-1/P-170 gene in patients with acute lymphoblastic leukemia. , 1989, Blood.

[96]  M. Azzaria,et al.  Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance , 1989, Molecular and cellular biology.

[97]  M. Hatzoglou,et al.  Increase in nitrosourea resistance in mammalian cells by retrovirally mediated gene transfer of bacterial O6-alkylguanine-DNA alkyltransferase. , 1989, Cancer research.

[98]  A. Y. Lu,et al.  Glutathione S-transferases: gene structure, regulation, and biological function. , 1989, Annual review of biochemistry.

[99]  I. Pastan,et al.  Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice: resistance to daunomycin-induced leukopenia , 1989, Molecular and cellular biology.

[100]  T. Tsuruo,et al.  In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52. , 1989, Cancer research.

[101]  G. Wahl,et al.  Recent progress in understanding mechanisms of mammalian DNA amplification , 1989, Cell.

[102]  V. Ling,et al.  Multidrug resistance in cancer. , 1989, Scientific American.

[103]  I. Roninson,et al.  Structure and expression of the human MDR (P-glycoprotein) gene family , 1989, Molecular and cellular biology.

[104]  W. McGuire,et al.  Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[105]  B. Stewart,et al.  Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein. , 1989, Cancer research.

[106]  M. Mattern,et al.  Nonproductive rearrangement of DNA topoisomerase I and II genes: correlation with resistance to topoisomerase inhibitors. , 1989, Journal of the National Cancer Institute.

[107]  D. J. Bosman,et al.  Evidence for a mutant allele of the gene for DNA topoisomerase II in adriamycin-resistant P388 murine leukemia cells. , 1989, Cancer research.

[108]  L. Liu,et al.  DNA topoisomerase poisons as antitumor drugs. , 1989, Annual review of biochemistry.

[109]  J. Bertino,et al.  Inherent resistance of human squamous carcinoma cell lines to methotrexate as a result of decreased polyglutamylation of this drug. , 1989, Cancer research.

[110]  B H Margolin,et al.  Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbrück fluctuation analysis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[111]  I. Pastan,et al.  Expression of Multidrug Resistance Gene in Human Cancers , 1989 .

[112]  J. Carl.  Drug-resistance patterns assessed from tumor marker analysis. , 1989, Journal of the National Cancer Institute.

[113]  K. Cowan,et al.  Glutathione S-transferase and drug resistance. , 1989, Cancer treatment and research.

[114]  I. Pastan,et al.  Clinical trials of agents that reverse multidrug-resistance. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[115]  V. Ling.  Does P-glycoprotein predict response to chemotherapy? , 1989, Journal of the National Cancer Institute.

[116]  T. Tsuruo,et al.  Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement. , 1989, Cancer research.

[117]  E. Mimnaugh,et al.  Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells. , 1989, Cancer research.

[118]  T. Chung,et al.  Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[119]  T. Tsuruo,et al.  Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. , 1989, Cancer research.

[120]  M. Melamed,et al.  Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[121]  T. Grogan,et al.  Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining. , 1989, Journal of the National Cancer Institute.

[122]  G. Wahl,et al.  The importance of circular DNA in mammalian gene amplification. , 1989, Cancer research.

[123]  W. T. Beck,et al.  Genetic characterization of the multidrug-resistant phenotype of VM-26-resistant human leukemic cells. , 1989, Cancer research.

[124]  A. Harris,et al.  Possible role of inhibition of glutathione S-transferase in the partial reversal of chlorambucil resistance by indomethacin in a Chinese hamster ovary cell line. , 1989, Cancer research.

[125]  S. Bates,et al.  Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation , 1989, Molecular and cellular biology.

[126]  S. de Jong,et al.  Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line. , 1990, Cancer research.

[127]  K. Cowan,et al.  Glutathione S-transferases and drug resistance. , 1990, Cancer cells.

[128]  K Ueda,et al.  Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. , 1990, The Journal of biological chemistry.

[129]  I. Pastan,et al.  Regulation of the multidrug resistance gene in regenerating rat liver. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[130]  T. Tsuruo,et al.  Distribution of multidrug resistance-associated P-glycoprotein in normal and neoplastic human tissue , 1990 .

[131]  V. Ling,et al.  Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[132]  A. Jongsma,et al.  Determination of the DNA content of a six-gene amplicon in the multidrug-resistant Chinese hamster cell line CHRB3 by flow karyotyping. , 1990, Cancer research.

[133]  D. Housman,et al.  Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line. , 1990, Cancer research.

[134]  D. Housman,et al.  Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells , 1990, Molecular and cellular biology.

[135]  F. Watt,et al.  DNA amplification is rare in normal human cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[136]  A. M. van der Bliek,et al.  Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA. , 1990, Cancer research.

[137]  M. Ouellette,et al.  The amplified H circle of methotrexate‐resistant leishmania tarentolae contains a novel P‐glycoprotein gene. , 1990, The EMBO journal.

[138]  K. Kohn,et al.  Sequence-selective topoisomerase II inhibition by anthracycline derivatives in SV40 DNA: relationship with DNA binding affinity and cytotoxicity. , 1990, Biochemistry.